{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:08:23Z","timestamp":1793038103104,"version":"4.5.0"},"reference-count":290,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003381","name":"Minist\u00e9rio da Educa\u00e7\u00e3o e Ci\u00eancia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50011\/2020"],"award-info":[{"award-number":["UIDB\/50011\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0126\/2020"],"award-info":[{"award-number":["LA\/P\/0126\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0059\/2020"],"award-info":[{"award-number":["LA\/P\/0059\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00772\/2020"],"award-info":[{"award-number":["UIDB\/00772\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/50011\/2020"],"award-info":[{"award-number":["UIDP\/50011\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/04033\/2025"],"award-info":[{"award-number":["UID\/04033\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0006\/2020 (DOI 10.54499\/LA\/P\/0006\/2020"],"award-info":[{"award-number":["LA\/P\/0006\/2020 (DOI 10.54499\/LA\/P\/0006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.critrevonc.2026.105184","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:00:09Z","timestamp":1770278409000},"page":"105184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hallmarks of cancer in canine mammary tumors: Insights into a potential model for human triple-negative breast cancer"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6652-9770","authenticated-orcid":false,"given":"Tiago","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o F.","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105184_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-017-4542-8","article-title":"Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance","volume":"167","author":"Abadie","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105184_bib2","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2018.8411","article-title":"Canine mammary tumors as a model for human disease (Review)","author":"Abdelmegeed","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105184_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.2174\/138161282205160127095338","article-title":"Cadherins: the superfamily critically involved in breast cancer","volume":"22","author":"Afzal Ashaie","year":"2016","journal-title":"CPD"},{"key":"10.1016\/j.critrevonc.2026.105184_bib4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s11033-018-4285-6","article-title":"Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications","volume":"45","author":"Amaral","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.rvsc.2016.03.020","article-title":"HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival","volume":"106","author":"Ara\u00fajo","year":"2016","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/vr.103398","article-title":"Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case\u2013control prospective study","volume":"179","author":"Arenas","year":"2016","journal-title":"Vet. Rec."},{"key":"10.1016\/j.critrevonc.2026.105184_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-021-06260-1","article-title":"M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma","volume":"188","author":"Arole","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105184_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.31557\/APJCP.2019.20.3.839","article-title":"Association of protein expression and methylation of DAPK1 with clinicopathological features in invasive ductal carcinoma patients from Kashmir","volume":"20","author":"Asiaf","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.critrevonc.2026.105184_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4048\/jbc.2015.18.3.256","article-title":"Epithelial-mesenchymal transition phenotype is associated with clinicopathological factors that indicate aggressive biological behavior and poor clinical outcomes in invasive breast cancer","volume":"18","author":"Bae","year":"2015","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3892\/mmr.2015.3560","article-title":"Transforming growth factor-\u03b2, insulin-like growth factor I\/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer","volume":"12","author":"Bahhnassy","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib11","series-title":"Cell Cycle Control, Methods in Molecular Biology","first-page":"29","article-title":"Cell Cycle Regulation by Checkpoints","author":"Barnum","year":"2014"},{"key":"10.1016\/j.critrevonc.2026.105184_bib12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1186\/s12885-019-5955-z","article-title":"Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines","volume":"19","author":"Barreno","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib14","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1038\/s41598-020-59260-4","article-title":"DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer","volume":"10","author":"Beetch","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib15","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1751-0813.2011.00803.x","article-title":"Canine mammary mixed tumours: immunohistochemical expressions of EGFR and HER-2: SMALL ANIMALS","volume":"89","author":"Bertagnolli","year":"2011","journal-title":"Aust. Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib16","first-page":"326","article-title":"The role of the microbiome in cancer development and therapy","volume":"67","author":"Bhatt","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105184_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.addr.2021.03.018","article-title":"The past, present, and future of breast cancer models for nanomedicine development","volume":"173","author":"Boix-Montesinos","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.critrevonc.2026.105184_bib18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12032-017-1019-x","article-title":"A comparative study of Ki-67 antigen expression between luminal A and triple-negative subtypes of breast cancer","volume":"34","author":"Borges","year":"2017","journal-title":"Med Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib19","doi-asserted-by":"crossref","first-page":"45745","DOI":"10.18632\/oncotarget.9935","article-title":"The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance","volume":"7","author":"Breslin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105184_bib20","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.devcel.2021.04.013","article-title":"Lipid metabolism in cancer: New perspectives and emerging mechanisms","volume":"56","author":"Broadfield","year":"2021","journal-title":"Dev. Cell"},{"key":"10.1016\/j.critrevonc.2026.105184_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0300985820973462","article-title":"p53, ER, and Ki67 expression in canine mammary carcinomas and correlation with pathological variables and prognosis","volume":"58","author":"Brunetti","year":"2021","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2020.105453","article-title":"Carnitine palmitoyltransferase 1 A expression profile in canine mammary tumors","volume":"257","author":"Cacciola","year":"2020","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122277","article-title":"Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366","volume":"10","author":"Caceres","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2026.105184_bib24","doi-asserted-by":"crossref","DOI":"10.15761\/JTS.1000432","article-title":"Long telomeres: a new prognostic factor for severity in triple-negative breast cancer patients","volume":"7","author":"Calvete","year":"2020","journal-title":"J. Transl. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/j.1939-1676.2012.01014.x","article-title":"CA 15-3, CRP, and LDH correlates with prognostic parameters in canine mammary neoplasms","volume":"26","author":"Campos","year":"2012","journal-title":"Vet. Intern. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib26","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.3390\/cancers17071102","article-title":"Molecular subtypes and mechanisms of breast cancer: precision medicine approaches for targeted therapies","volume":"17","author":"Carvalho","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105184_bib27","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.rvsc.2013.09.003","article-title":"EGFR and microvessel density in canine malignant mammary tumours","volume":"95","author":"Carvalho","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/920409","article-title":"Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors","volume":"2015","author":"Carvalho","year":"2015","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2016.06.006","article-title":"Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors","volume":"178","author":"Carvalho","year":"2016","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib30","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.21873\/anticanres.13319","article-title":"Assessing the interleukin 35 immunoexpression in malignant canine mammary tumors: association with clinicopathological parameters and prognosis","volume":"39","author":"Carvalho","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib31","first-page":"963","article-title":"T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications","volume":"25","author":"Carvalho","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.critrevonc.2026.105184_bib32","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/vco.12206","article-title":"High COX-2 expression is associated with increased angiogenesis, proliferation and tumoural inflammatory infiltrate in canine malignant mammary tumours: a multivariate survival study","volume":"15","author":"Carvalho","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1017\/S146039691200057X","article-title":"Significance of serum vascular endothelial growth factor and cancer antigen 15.3 in patients with triple negative breast cancer","volume":"13","author":"Chanana","year":"2014","journal-title":"J. Radiother. Pract."},{"key":"10.1016\/j.critrevonc.2026.105184_bib34","doi-asserted-by":"crossref","first-page":"079","DOI":"10.4103\/0974-2727.163129","article-title":"Epidermal growth factor receptor expression in triple negative and nontriple negative breast carcinomas","volume":"7","author":"Changavi","year":"2015","journal-title":"J. Lab Physicians"},{"key":"10.1016\/j.critrevonc.2026.105184_bib35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/15419069909010805","article-title":"Role of carbohydrate structures in CEA-mediated intercellular adhesion","volume":"7","author":"Charbonneau","year":"1999","journal-title":"Cell Adhes. Commun."},{"key":"10.1016\/j.critrevonc.2026.105184_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2017.08.004","article-title":"Epigenetic drivers of tumourigenesis and cancer metastasis","volume":"51","author":"Chatterjee","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib37","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105184_bib38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","article-title":"Regulating tumor suppressor genes: post-translational modifications","volume":"5","author":"Chen","year":"2020","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2026.105184_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41392-018-0018-5","article-title":"The independence of and associations among apoptosis, autophagy, and necrosis","volume":"3","author":"Chen","year":"2018","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2026.105184_bib40","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1002\/jcb.26739","article-title":"microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1","volume":"119","author":"Chen","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105184_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s12032-014-0989-1","article-title":"COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients","volume":"31","author":"Chikman","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib42","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.3390\/jcm9103153","article-title":"Expression of MTDH and IL-10 is an independent predictor of worse prognosis in ER-negative or PR-negative breast cancer patients","volume":"9","author":"Chu","year":"2020","journal-title":"JCM"},{"key":"10.1016\/j.critrevonc.2026.105184_bib43","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4161\/cc.9.11.11849","article-title":"Checkpoint bypass and cell viability","volume":"9","author":"Chung","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.critrevonc.2026.105184_bib44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tvjl.2013.02.009","article-title":"Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer","volume":"197","author":"Clemente","year":"2013","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1470-2045(17)30891-4","article-title":"Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study","volume":"19","author":"Copson","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141763","article-title":"Analysis of PIK3CA mutations and activation pathways in triple negative breast cancer","volume":"10","author":"Cossu-Rocca","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2026.105184_bib47","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer","volume":"33","author":"Couch","year":"2015","journal-title":"JCO"},{"key":"10.1016\/j.critrevonc.2026.105184_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161902","article-title":"Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients","volume":"11","author":"Dai","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2026.105184_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.vetimm.2012.12.010","article-title":"Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer","volume":"152","author":"De Andr\u00e9s","year":"2013","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib50","first-page":"506","article-title":"Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment","volume":"50","author":"de M Souza","year":"2009","journal-title":"Can. Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.22034","article-title":"Phenotype-rescue of cyclin-dependent kinase inhibitor p16\/INK4A defects in a spontaneous canine cell model of breast cancer","volume":"106","author":"DeInnocentes","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105184_bib52","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.onc.1203269","article-title":"Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation","volume":"19","author":"Deng","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105184_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jcpa.2008.12.005","article-title":"COX-2 expression in canine normal and neoplastic mammary gland","volume":"140","author":"Dias Pereira","year":"2009","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/annonc\/mdt556","article-title":"Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study","volume":"25","author":"Dieci","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.rvsc.2016.02.004","article-title":"Evaluation of apoptosis-associated protein (Bcl-2, Bax, cleaved caspase-3 and p53) expression in canine mammary tumors: an immunohistochemical and prognostic study","volume":"105","author":"Dolka","year":"2016","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12032-014-0057-x","article-title":"High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation","volume":"31","author":"Dong","year":"2014","journal-title":"Med Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1354\/vp.40-2-207","article-title":"Cyclooxygenase-2 expression in canine mammary tumors","volume":"40","author":"Dor\u00e9","year":"2003","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib58","first-page":"3","article-title":"Deregulation of VEGFR-2 and PDGFR expression and microvascular density in a triple-negative model of canine malignant mammary tumors with lymph node or lung metastasis","volume":"6","author":"Dos Anjos","year":"2019","journal-title":"Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/BCTT.S405719","article-title":"Androgen receptor status in triple negative breast cancer: does it correlate with clinicopathological characteristics?","volume":"15","author":"Dubrava","year":"2023","journal-title":"BCTT"},{"key":"10.1016\/j.critrevonc.2026.105184_bib60","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/COC.0b013e3181b8afcf","article-title":"Triple-negative breast cancer: a short review","volume":"33","author":"Elias","year":"2010","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12885-018-4029-y","article-title":"Prevalence of pathogenic BRCA1\/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history","volume":"18","author":"Engel","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib62","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/1471-2407-10-256","article-title":"Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates","volume":"10","author":"Estrela-Lima","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib63","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1038\/s41598-021-85029-4","article-title":"Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients","volume":"11","author":"Fan","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Sig Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2026.105184_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.577420","article-title":"Alterations of lipid metabolism in cancer: implications in prognosis and treatment","volume":"10","author":"Fern\u00e1ndez","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib66","article-title":"Current views on in vivo models for breast cancer research and related drug development","volume":"19","author":"Ferreira","year":"2023","journal-title":"Expert Opin. Drug Discov. 1"},{"key":"10.1016\/j.critrevonc.2026.105184_bib67","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-024-01260-7","article-title":"Exploring the role of microRNAs as diagnostic and prognostic biomarkers in canine mammary tumors","author":"Ferreira","year":"2024","journal-title":"GeroScience"},{"key":"10.1016\/j.critrevonc.2026.105184_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ani15010020","article-title":"Let-7b, miR-29b, and miR-125b as potential biomarkers for differentiating canine mammary carcinoma histological types","volume":"15","author":"Ferreira","year":"2024","journal-title":"Animals"},{"key":"10.1016\/j.critrevonc.2026.105184_bib69","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.14202\/vetworld.2024.1052-1072","article-title":"Contribution of non-steroidal anti-inflammatory drugs to breast cancer treatment: in vitro and in vivo studies","author":"Ferreira","year":"2024","journal-title":"Vet. World"},{"key":"10.1016\/j.critrevonc.2026.105184_bib70","first-page":"379","article-title":"Mammary glands of women, female dogs and female rats: similarities and differences to be considered in breast cancer research","volume":"10","author":"Ferreira","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.rvsc.2025.105816","article-title":"Hormone receptor discrepancy and molecular subtype changes in canine mammary carcinomas and synchronous lymph node metastasis","volume":"194","author":"Ferreira","year":"2025","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib72","first-page":"409","article-title":"Integrated study of canine mammary tumors histopathology, immunohistochemistry, and cytogenetic findings","volume":"11","author":"Ferreira","year":"2024","journal-title":"Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/341654","article-title":"FOXP3 Transcription Factor: a candidate marker for susceptibility and prognosis in triple negative breast cancer","volume":"2014","author":"Fiori Lopes","year":"2014","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.critrevonc.2026.105184_bib74","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1186\/s12885-018-4750-6","article-title":"Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks","volume":"18","author":"Fish","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib75","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/jvim.15764","article-title":"Circulating microRNA as biomarkers of canine mammary carcinoma in dogs","volume":"34","author":"Fish","year":"2020","journal-title":"Vet. Intern. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00418-008-0424-9","article-title":"Tight junctions and the modulation of barrier function in disease","volume":"130","author":"F\u00f6rster","year":"2008","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.rvsc.2019.08.021","article-title":"Tumor-infiltrating CD4+ and CD8+ lymphocytes and macrophages are associated with prognostic factors in triple-negative canine mammary complex type carcinoma","volume":"126","author":"Franzoni","year":"2019","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1354\/vp.37-2-177","article-title":"Cellular proliferative and telomerase activity in canine mammary gland tumors","volume":"37","author":"Funakoshi","year":"2000","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib80","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/ijms25021170","article-title":"Programmed death-ligand (PD-L1), epidermal growth factor (EGF), relaxin, and matrix metalloproteinase-3 (MMP3): potential biomarkers of malignancy in canine mammary neoplasia","volume":"25","author":"Galadima","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.critrevonc.2026.105184_bib81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tvjl.2009.02.001","article-title":"Expression and prognostic significance of CK19 in canine malignant mammary tumours","volume":"184","author":"Gama","year":"2010","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00428-008-0644-3","article-title":"Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification","volume":"453","author":"Gama","year":"2008","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2026.105184_bib83","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.rvsc.2009.04.016","article-title":"Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues","volume":"87","author":"Gama","year":"2009","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tvjl.2007.05.024","article-title":"Expression of E-cadherin, P-cadherin and \u03b2-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival","volume":"177","author":"Gama","year":"2008","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/357187","article-title":"Cadherin cell adhesion system in canine mammary cancer: a review","volume":"2012","author":"Gama","year":"2012","journal-title":"Vet. Med. Int."},{"key":"10.1016\/j.critrevonc.2026.105184_bib86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/cancers15010324","article-title":"Physical exercise and the hallmarks of breast cancer: a narrative review","volume":"15","author":"Garc\u00eda-Chico","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105184_bib87","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s13058-014-0488-5","article-title":"Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer","volume":"16","author":"Garc\u00eda-Mart\u00ednez","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib88","doi-asserted-by":"crossref","DOI":"10.4137\/CMO.S34540","article-title":"Tumor-infiltrating lymphocytes in triple negative breast cancer: the future of immune targeting","volume":"10s1","author":"Garc\u00eda-Teijido","year":"2016","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib89","doi-asserted-by":"crossref","first-page":"76","DOI":"10.17221\/7316-VETMED","article-title":"Aberrant cytoplasmic accumulation of retinoblastoma protein in basal cells may lead to increased survival in malignant canine mammary tumours","volume":"59","author":"Gautam","year":"2014","journal-title":"Vet. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib90","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ctrv.2018.06.005","article-title":"Androgen receptor in triple negative breast cancer: a potential target for the targetless subtype","volume":"68","author":"Gerratana","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2026.105184_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2023.106055","article-title":"Profiling canine mammary tumors: a potential model for studying human breast cancer","volume":"303","author":"Gherman","year":"2024","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13008-015-0009-7","article-title":"Aneuploidy and chromosomal instability in cancer: a jackpot to chaos","volume":"10","author":"Giam","year":"2015","journal-title":"Cell Div."},{"key":"10.1016\/j.critrevonc.2026.105184_bib93","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.7314\/APJCP.2015.16.6.2129","article-title":"Molecular mechanisms of apoptosis and roles in cancer development and treatment","volume":"16","author":"Goldar","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.critrevonc.2026.105184_bib94","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","article-title":"Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer","volume":"17","author":"Gonzalez-Angulo","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2017.10.008","article-title":"Epidermal growth factor receptor overexpression and outcomes in early breast cancer: a systematic review and a meta-analysis","volume":"62","author":"Gonzalez-Conchas","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2026.105184_bib96","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.7150\/jca.30410","article-title":"BRCA genes: the role in genome stability, cancer stemness and therapy resistance","volume":"10","author":"Gorodetska","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib97","doi-asserted-by":"crossref","first-page":"691","DOI":"10.6004\/jnccn.2022.0030","article-title":"Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gradishar","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.critrevonc.2026.105184_bib98","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105184_bib99","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcpa.2013.07.005","article-title":"Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours","volume":"150","author":"Guimar\u00e3es","year":"2014","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"G\u00fcnzel","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.critrevonc.2026.105184_bib101","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.1038\/s41388-020-01405-w","article-title":"Targeting telomerase for cancer therapy","volume":"39","author":"Guterres","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105184_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105184_bib103","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105184_bib104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105184_bib105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.critrevonc.2026.105184_bib106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0304-3835(02)00701-2","article-title":"Biochemical aspects of telomerase function","volume":"194","author":"Harrington","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105184_bib107","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/cncr.26576","article-title":"Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer","volume":"118","author":"Hartman","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib108","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.3390\/cancers13246209","article-title":"The role of breast cancer stem cells in chemoresistance and metastasis in triple-negative breast cancer","volume":"13","author":"He","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105184_bib109","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1354\/vp.42-6-776","article-title":"Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma","volume":"42","author":"Heller","year":"2005","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib110","article-title":"Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Hern\u00e1ndez Borrero","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib111","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/1535370216641787","article-title":"Role of mitochondrial dysfunction in cancer progression","volume":"241","author":"Hsu","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.critrevonc.2026.105184_bib112","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tvjl.2012.07.014","article-title":"Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors","volume":"195","author":"Im","year":"2013","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib113","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/0300985813498780","article-title":"Analysis of a new histological and molecular-based classification of canine mammary neoplasia","volume":"51","author":"Im","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib114","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2559.2012.04255.x","article-title":"Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer","volume":"61","author":"Iqbal","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2026.105184_bib115","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s12885-015-1670-6","article-title":"The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study","volume":"15","author":"Jaillardon","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib116","article-title":"Abstract 85: Prognostic stratification of naturally occurring canine triple negative invasive mammary carcinoma according to IGF1-R and AR expression","author":"Jaillardon","year":"2014","journal-title":"Tumor Biology. Presented at the Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA, American Association for Cancer Research"},{"key":"10.1016\/j.critrevonc.2026.105184_bib117","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10577-021-09652-7","article-title":"CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors","volume":"29","author":"Jain","year":"2021","journal-title":"Chromosome Res"},{"key":"10.1016\/j.critrevonc.2026.105184_bib118","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jcpa.2008.08.001","article-title":"Expression of claudin-1, -2, -3, -4, -5 and -7 proteins in benign and malignant canine mammary gland epithelial tumours","volume":"139","author":"Jakab","year":"2008","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib119","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13193-014-0290-y","article-title":"Role of Cyclooxygenase 2 (COX-2) in prognosis of breast cancer","volume":"5","author":"Jana","year":"2014","journal-title":"Indian J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib120","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","article-title":"Cell adhesion in cancer: beyond the migration of single cells","volume":"295","author":"Janiszewska","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105184_bib121","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.14202\/vetworld.2016.1489-1492","article-title":"Altered oxidative stress and carbohydrate metabolism in canine mammary tumors","volume":"9","author":"Jayasri","year":"2016","journal-title":"Vet. World"},{"key":"10.1016\/j.critrevonc.2026.105184_bib122","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1172\/JCI81568","article-title":"RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation","volume":"126","author":"Jones","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2026.105184_bib123","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/10799893.2012.664552","article-title":"EGFR overexpression relates to triple negative profile and poor prognosis in breast cancer patients in Tunisia","volume":"32","author":"Kallel","year":"2012","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.critrevonc.2026.105184_bib124","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bjc.6605735","article-title":"Significance of E-cadherin expression in triple-negative breast cancer","volume":"103","author":"Kashiwagi","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib125","first-page":"526","article-title":"The novel diagnostic techniques and biomarkers of canine mammary tumors","volume":"9","author":"Kaszak","year":"2022","journal-title":"Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib126","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.3390\/ijms21207624","article-title":"Role of cadherins in cancer\u2014a review","volume":"21","author":"Kaszak","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.critrevonc.2026.105184_bib127","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/pin.12560","article-title":"Expression patterns of claudins in patients with triple-negative breast cancer are associated with nodal metastasis and worse outcome","volume":"67","author":"Katayama","year":"2017","journal-title":"Pathol. Int."},{"key":"10.1016\/j.critrevonc.2026.105184_bib128","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/molecules26041076","article-title":"Molecular targeting of epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR)","volume":"26","author":"Kaufman","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.critrevonc.2026.105184_bib129","first-page":"146","article-title":"Breed- and age-related differences in canine mammary tumors","volume":"80","author":"Kim","year":"2016","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rvsc.2020.09.001","article-title":"PIK3CA mutations matter for cancer in dogs","volume":"133","author":"Kim","year":"2020","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib131","first-page":"142","article-title":"Correlation of tumor-infiltrating lymphocytes to histopathological features and molecular phenotypes in canine mammary carcinoma: a morphologic and immunohistochemical morphometric study","volume":"77","author":"Kim","year":"2013","journal-title":"Can. J. Vet. Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib132","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.tvjl.2011.10.022","article-title":"Correlation of Foxp3 positive regulatory T cells with prognostic factors in canine mammary carcinomas","volume":"193","author":"Kim","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib133","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcpa.2009.10.023","article-title":"Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours","volume":"142","author":"Kim","year":"2010","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib134","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcpa.2012.08.009","article-title":"Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers","volume":"148","author":"Kim","year":"2013","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib135","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1038\/s41467-020-17458-0","article-title":"Cross-species oncogenic signatures of breast cancer in canine mammary tumors","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105184_bib136","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1354\/vp.08-VP-0212-K-FL","article-title":"Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas","volume":"46","author":"Klopfleisch","year":"2009","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib137","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1021\/pr100671c","article-title":"Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer","volume":"9","author":"Klopfleisch","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib138","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib139","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221122725","article-title":"Clinical validity and clinical utility of Ki67 in early breast cancer","volume":"14","author":"Kreipe","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jvim.13812","article-title":"Effect of ovariohysterectomy at the time of tumor removal in dogs with mammary carcinomas: a randomized controlled trial","volume":"30","author":"Kristiansen","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib141","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1172\/JCI99673","article-title":"\u0394Np63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer","volume":"128","author":"Kumar","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.critrevonc.2026.105184_bib142","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/biology10020167","article-title":"Proteolytic cleavages in the VEGF family: generating diversity among angiogenic VEGFs, essential for the activation of lymphangiogenic VEGFs","volume":"10","author":"K\u00fcnnapuu","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.critrevonc.2026.105184_bib143","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.14798","article-title":"Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival","volume":"1514","author":"Kuo","year":"2022","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105184_bib144","doi-asserted-by":"crossref","DOI":"10.4048\/jbc.2023.26.e4","article-title":"Canine as a comparative and translational model for human mammary tumor","volume":"26","author":"Kwon","year":"2023","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib145","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1354\/vp.08-VP-0226-C-FL","article-title":"Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival","volume":"46","author":"Lavalle","year":"2009","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib146","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4142\/jvs.2004.5.1.63","article-title":"Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors","volume":"5","author":"Lee","year":"2004","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib147","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4142\/jvs.2002.3.4.321","article-title":"Mutations of p53 tumor suppressor gene in spontaneous canine mammary tumors","volume":"3","author":"Lee","year":"2002","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib148","doi-asserted-by":"crossref","first-page":"349","DOI":"10.30802\/AALAS-CM-20-000013","article-title":"PKM2 in canine mammary tumors: parallels to human breast cancer","volume":"70","author":"Lee","year":"2020","journal-title":"Comp. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib149","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.025","article-title":"Cancer epigenetics: past, present and future","volume":"83","author":"Lee","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/cancers10090317","article-title":"Transcriptome signatures of canine mammary gland tumors and its comparison to human breast cancers","volume":"10","author":"Lee","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105184_bib151","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/0284186X.2012.731520","article-title":"Prognostic impact of FOXP3 expression in triple-negative breast cancer","volume":"52","author":"Lee","year":"2013","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib152","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/ani11030658","article-title":"High intrinsic expression of P-glycoprotein and breast cancer resistance protein in canine mammary carcinomas regardless of immunophenotype and outcome","volume":"11","author":"Levi","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.critrevonc.2026.105184_bib153","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3892\/ol.2014.2618","article-title":"Ki67 as a predictor of poor prognosis in patients with triple-negative breast cancer","volume":"9","author":"Li","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105184_bib154","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Ki67 is a promising molecular target in the diagnosis of cancer (Review)","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib155","article-title":"A novel canine mammary cancer cell line: preliminary identification and utilization for drug screening studies","volume":"8","author":"Li","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib156","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib157","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib158","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tvjl.2015.01.005","article-title":"Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors","volume":"203","author":"Lim","year":"2015","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib159","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/annonc\/mdp062","article-title":"Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer","volume":"20","author":"Linderholm","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib160","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5603\/NJO.a2022.0035","article-title":"Cyclooxygenase-2 and Bcl-2 expression in patients with triple-negative breast cancer","volume":"72","author":"Liszcz-Tymoszuk","year":"2022","journal-title":"Nowotw. J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib161","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","article-title":"Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity","volume":"15","author":"Liu","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.critrevonc.2026.105184_bib162","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1158\/0008-5472.CAN-14-0392","article-title":"Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer","volume":"74","author":"Liu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib163","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/030098589703400306","article-title":"Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA","volume":"34","author":"L\u00f6hr","year":"1997","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib164","first-page":"82","article-title":"LncRNA expression profiles in canine mammary tumors identify lnc34977 as a promoter of proliferation, migration and invasion of canine mammary tumor cells","volume":"9","author":"Lu","year":"2022","journal-title":"Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib165","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib166","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/jcb.24300","article-title":"Novel frameshift mutation in the p16\/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16\/INK4A\/p14ARF locus","volume":"114","author":"Lutful Kabir","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105184_bib167","first-page":"628","article-title":"Knockdown of pyruvate kinase M inhibits cell growth and migration by reducing NF-kB activity in triple-negative breast cancer cells","volume":"42","author":"Ma","year":"2019","journal-title":"Mol. Cells"},{"key":"10.1016\/j.critrevonc.2026.105184_bib168","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1040638719898686","article-title":"Triple-negative mammary carcinoma in two male dogs","volume":"32","author":"Machado","year":"2020","journal-title":"J. Vet. Diagn. Invest."},{"key":"10.1016\/j.critrevonc.2026.105184_bib169","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.ajpath.2014.08.020","article-title":"Stromal expression of miR-21 identifies high-risk group in triple-negative breast cancer","volume":"184","author":"MacKenzie","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1746-6148-8-86","article-title":"CA 15\u20133 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade","volume":"8","author":"Manuali","year":"2012","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/srep33435","article-title":"DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients","volume":"6","author":"Mathe","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib172","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jcpa.2005.10.004","article-title":"E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables","volume":"134","author":"Matos","year":"2006","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib173","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1471-2407-12-306","article-title":"The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients","volume":"12","author":"Medrek","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib174","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/j.rvsc.2011.01.014","article-title":"Metabolic correlates of tumour hypoxia in malignant canine mammary carcinoma","volume":"91","author":"Mees","year":"2011","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.744032","article-title":"Establishment of a new cell line of canine mammary tumor CMT-1026","volume":"8","author":"Mei","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib176","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib177","doi-asserted-by":"crossref","first-page":"33577","DOI":"10.18632\/oncotarget.26094","article-title":"MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer","volume":"9","author":"Milevskiy","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105184_bib178","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcpa.2009.06.004","article-title":"Expression of vascular endothelial growth factor in canine inflammatory and non-inflammatory mammary carcinoma","volume":"142","author":"Millanta","year":"2010","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib179","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10549-005-9138-z","article-title":"COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic fmolecular markers","volume":"98","author":"Millanta","year":"2006","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105184_bib180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 expression in triple-negative breast cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib181","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tvjl.2018.02.016","article-title":"Tumour-associated macrophages: relation with progression and invasiveness, and assessment of M1\/M2 macrophages in canine mammary tumours","volume":"234","author":"Monteiro","year":"2018","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib182","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/cncr.22836","article-title":"Differences in breast carcinoma characteristics in newly diagnosed African\u2013American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute\u2019s Surveillance, Epidemiology, and end results database","volume":"110","author":"Morris","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib183","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3892\/mco.2014.327","article-title":"Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients","volume":"2","author":"Mosalpuria","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib184","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1177\/0300985816634808","article-title":"Immunosuppression in dogs during mammary cancer development","volume":"53","author":"Mucha","year":"2016","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib185","first-page":"34","article-title":"Immunostaining for p53 and p16CDKN2A protein is not predictive of prognosis for dogs with malignant mammary gland neoplasms","volume":"6","author":"Munday","year":"2019","journal-title":"Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib186","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/jcpa.2002.0631","article-title":"BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables","volume":"128","author":"Nieto","year":"2003","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib187","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011908","article-title":"Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases","volume":"4","author":"Nistico","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib188","first-page":"233","article-title":"Expression of E-cadherin, beta-catenin and Ki-67 antigen and their reciprocal relationships in mammary adenocarcinomas in bitches","volume":"45","author":"Nowak","year":"2007","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib189","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13620-016-0068-3","article-title":"Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas","volume":"69","author":"Nowak","year":"2015","journal-title":"Ir. Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib190","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s12276-023-00977-3","article-title":"Comparative oncology: overcoming human cancer through companion animal studies","volume":"55","author":"Oh","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib191","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5483\/BMBRep.2017.50.3.189","article-title":"Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib192","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/1040638717721730","article-title":"TP53 gene expression levels and tumor aggressiveness in canine mammary carcinomas","volume":"29","author":"Oliveira","year":"2017","journal-title":"J. Vet. Diagn. Invest."},{"key":"10.1016\/j.critrevonc.2026.105184_bib193","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5301\/ijbm.5000291","article-title":"Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients","volume":"33","author":"Ozretic","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.critrevonc.2026.105184_bib194","article-title":"P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients","volume":"12","author":"Pan","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2026.105184_bib195","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/104063870601800407","article-title":"Evaluation of telomerase in canine mammary tissues by immunohistochemical analysis and a polymerase chain reaction-based enzyme-linked immunosorbent assay","volume":"18","author":"Panarese","year":"2006","journal-title":"J. Vet. Diagn. Invest."},{"key":"10.1016\/j.critrevonc.2026.105184_bib196","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/cancers3021744","article-title":"Canine mammary cancer stem cells are radio- and chemo- resistant and exhibit an epithelial-mesenchymal transition phenotype","volume":"3","author":"Pang","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105184_bib197","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/ani13030505","article-title":"Confirmation of the prognostic value of Foxp3+ cells in canine mammary tumors","volume":"13","author":"Parisi","year":"2023","journal-title":"Animals"},{"key":"10.1016\/j.critrevonc.2026.105184_bib198","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/vco.12603","article-title":"Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours","volume":"18","author":"Pastor","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib199","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2022.02.003","article-title":"Vimentin: regulation and pathogenesis","volume":"197","author":"Paulin","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.critrevonc.2026.105184_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/217185","article-title":"Molecular basis of triple negative breast cancer and implications for therapy","volume":"2012","author":"Peddi","year":"2012","journal-title":"Int. J. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib201","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/0300985813509388","article-title":"Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry","volume":"51","author":"Pe\u00f1a","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/104063879801000303","article-title":"Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables","volume":"10","author":"Pe\u00f1a","year":"1998","journal-title":"J. Vet. Diagn. Invest."},{"key":"10.1016\/j.critrevonc.2026.105184_bib203","doi-asserted-by":"crossref","DOI":"10.1590\/1984-3143-ar2022-0086","article-title":"CA 15-3, CRP, and LDH correlates with prognostic parameters in canine mammary neoplasms","volume":"20","author":"Pinheiro","year":"2023","journal-title":"Anim. Reprod."},{"key":"10.1016\/j.critrevonc.2026.105184_bib204","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.3390\/ijms20246241","article-title":"Do mutations turn p53 into an oncogene?","volume":"20","author":"Pitolli","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.critrevonc.2026.105184_bib205","doi-asserted-by":"crossref","first-page":"948","DOI":"10.30574\/wjarr.2022.16.2.1249","article-title":"Telomerase: A link between cancer and biological immortality","volume":"16","author":"Prathibha","year":"2022","journal-title":"World J. Adv. Res. Rev."},{"key":"10.1016\/j.critrevonc.2026.105184_bib206","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3390\/life11111247","article-title":"Role of PTEN, PI3K, and mTOR in triple-negative breast cancer","volume":"11","author":"Prvanovi\u0107","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.critrevonc.2026.105184_bib207","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.rvsc.2007.10.015","article-title":"Expression and significance of PTEN in canine mammary gland tumours","volume":"85","author":"Qiu","year":"2008","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib208","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11259-008-9049-7","article-title":"Expression and significance of PTEN and VEGF in canine mammary gland tumours","volume":"32","author":"Qiu","year":"2008","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105184_bib209","article-title":"Tumor-associated macrophages: key players in triple-negative breast cancer","volume":"12","author":"Qiu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jcpa.2007.01.010","article-title":"Expression of Cox-1 and Cox-2 in canine mammary tumours","volume":"136","author":"Queiroga","year":"2007","journal-title":"J. Comp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib211","first-page":"4269","article-title":"Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance","volume":"25","author":"Queiroga","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib212","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rvsc.2009.10.009","article-title":"The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours","volume":"88","author":"Queiroga","year":"2010","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib213","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tvjl.2010.06.022","article-title":"COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer","volume":"189","author":"Queiroga","year":"2011","journal-title":"Vet. J."},{"key":"10.1016\/j.critrevonc.2026.105184_bib214","first-page":"455","article-title":"Canine mammary tumours as a model to study human breast cancer: most recent findings","volume":"25","author":"Queiroga","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.critrevonc.2026.105184_bib215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12915-023-01516-2","article-title":"Establishment and characterization of canine mammary tumoroids for translational research","volume":"21","author":"Raffo-Romero","year":"2023","journal-title":"BMC Biol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib216","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11259-021-09861-9","article-title":"MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors","volume":"46","author":"Ramadan","year":"2022","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105184_bib217","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1476-5829.2012.00326.x","article-title":"Prognostic value of tumour-associated macrophages in canine mammary tumours","volume":"12","author":"Raposo","year":"2014","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib218","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/vco.12067","article-title":"Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours","volume":"13","author":"Raposo","year":"2015","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib219","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/s41598-023-28389-3","article-title":"Expression and significance of IL-6 and IL-8 in canine mammary gland tumors","volume":"13","author":"Ren","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib220","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2147\/OTT.S162381","article-title":"5-Azacytidine treatment induces demethylation of DAPK1 and MGMT genes and inhibits growth in canine mammary gland tumor cells","volume":"11","author":"Ren","year":"2018","journal-title":"OTT"},{"key":"10.1016\/j.critrevonc.2026.105184_bib221","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1354\/vp.08-VP-0273-P-FL","article-title":"Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors","volume":"46","author":"Ressel","year":"2009","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib222","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1354\/vp.39-4-488","article-title":"Expression of vascular endothelial growth factor in canine mammary tumors","volume":"39","author":"Restucci","year":"2002","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib223","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/br.2014.312","article-title":"Expression of vimentin filaments in canine malignant mammary gland tumors: a simulation of clinicopathological features of human breast cancer","volume":"2","author":"Rismanchi","year":"2014","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib224","doi-asserted-by":"crossref","first-page":"8770","DOI":"10.1158\/0008-5472.CAN-09-1725","article-title":"Mammary tumor development in dogs is associated with BRCA1 and BRCA2","volume":"69","author":"Rivera","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib225","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/ani13050926","article-title":"Parameters of metabolic response to surgical trauma induced via unilateral total mastectomy associated or not to ovariohysterectomy in dogs","volume":"13","author":"Rodigheri","year":"2023","journal-title":"Animals"},{"key":"10.1016\/j.critrevonc.2026.105184_bib226","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1556\/004.2016.009","article-title":"Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours","volume":"64","author":"Rodrigues","year":"2016","journal-title":"Acta Vet. Hung."},{"key":"10.1016\/j.critrevonc.2026.105184_bib227","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib228","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.molmed.2011.02.004","article-title":"Dog models of naturally occurring cancer","volume":"17","author":"Rowell","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib229","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1292\/jvms.11-0118","article-title":"Significance of tumor-infiltrating immune cells in spontaneous canine mammary gland tumor: 140 cases","volume":"74","author":"Saeki","year":"2012","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib230","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/life12091332","article-title":"P16INK4A\u2014more than a senescence marker","volume":"12","author":"Safwan-Zaiter","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.critrevonc.2026.105184_bib231","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12917-021-02901-1","article-title":"Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma","volume":"17","author":"S\u00e1nchez-C\u00e9spedes","year":"2021","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib232","doi-asserted-by":"crossref","DOI":"10.1111\/vco.12107","article-title":"VEGFR-2 expression in malignant tumours of the canine mammary gland: a prospective survival study","volume":"14","author":"Santos","year":"2016","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib233","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1746-6148-6-5","article-title":"Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry","volume":"6","author":"Sassi","year":"2010","journal-title":"BMC Vet. Res"},{"key":"10.1016\/j.critrevonc.2026.105184_bib234","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/biomedicines8110526","article-title":"Mitochondria at work: new insights into regulation and dysregulation of cellular energy supply and metabolism","volume":"8","author":"Schirrmacher","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.critrevonc.2026.105184_bib235","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1257932","article-title":"Expression of acetylated histones H3 and H4 and histone deacetylase enzymes HDAC1, HDAC2 and HDAC6 in simple mammary carcinomas of female dogs","volume":"14","author":"Senhorello","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2026.105184_bib236","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0300985817750457","article-title":"CD204-expressing tumor-associated macrophages are associated with malignant, high-grade, and hormone receptor\u2013negative canine mammary gland tumors","volume":"55","author":"Seung","year":"2018","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib237","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"The clonal and mutational evolution spectrum of primary triple-negative breast cancers","volume":"486","author":"Shah","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105184_bib238","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133830","article-title":"Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer","volume":"10","author":"Shao","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.critrevonc.2026.105184_bib239","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10549-014-2980-0","article-title":"Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and\/or ovarian cancer syndrome testing","volume":"145","author":"Sharma","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2026.105184_bib240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-018-0850-9","article-title":"Therapeutic landscape in mutational triple negative breast cancer","volume":"17","author":"Shi","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib241","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105184_bib242","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s13193-023-01780-2","article-title":"Epigenetic silencing of p16INK4a gene in sporadic breast cancer","volume":"14","author":"Singh","year":"2023","journal-title":"Indian J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib243","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/gcc.22481","article-title":"The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer","volume":"56","author":"Slattery","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib244","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00018-019-03369-x","article-title":"Structural biology of telomeres and telomerase","volume":"77","author":"Smith","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib245","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.13722","article-title":"The cell proliferation antigen Ki-67 organises heterochromatin","volume":"5","author":"Sobecki","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.critrevonc.2026.105184_bib246","doi-asserted-by":"crossref","first-page":"496","DOI":"10.20892\/j.issn.2095-3941.2016.0066","article-title":"Ki-67 as a prognostic marker according to breast cancer molecular subtype","volume":"13","author":"Soliman","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105184_bib247","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jclinpath-2016-204222","article-title":"Prognostic value of vitamin D receptor and insulin-like growth factor receptor 1 expression in triple-negative breast cancer","volume":"71","author":"Soljic","year":"2018","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib248","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08645","article-title":"Complex landscapes of somatic rearrangement in human breast cancer genomes","volume":"462","author":"Stephens","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105184_bib249","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/vco.12224","article-title":"Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour","volume":"15","author":"Surdyka","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib250","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/vco.12247","article-title":"Defect in ND2, COX2, ATP6 and COX3 mitochondrial genes as a risk factor for canine mammary tumour","volume":"15","author":"Surdyka","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib251","doi-asserted-by":"crossref","first-page":"194","DOI":"10.29261\/pakvetj\/2018.043","article-title":"Comparison of plasma interleukin-6 and interleukin-10 concentrations between female dogs with mammary gland tumours and healthy","volume":"38","author":"Szczubia\u0142","year":"2018","journal-title":"PVJ"},{"key":"10.1016\/j.critrevonc.2026.105184_bib252","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2013.01.042","article-title":"Microenvironment and tumor cell plasticity: an easy way out","volume":"341","author":"Taddei","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105184_bib253","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00428-019-02635-4","article-title":"The role of Ki-67 in Asian triple negative breast cancers: a novel combinatory panel approach","volume":"475","author":"Tan","year":"2019","journal-title":"Virchows Arch."},{"key":"10.1016\/j.critrevonc.2026.105184_bib254","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12885-021-08134-7","article-title":"Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer","volume":"21","author":"Tan","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.canlet.2013.01.024","article-title":"Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer","volume":"332","author":"Tang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105184_bib256","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3389\/fonc.2019.01257","article-title":"Canine cancer: strategies in experimental therapeutics","volume":"9","author":"Thamm","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib257","first-page":"897","article-title":"KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival","volume":"10","author":"Tokumaru","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib258","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/annonc\/mdp209","article-title":"High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy","volume":"20","author":"Trer\u00e9","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib259","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","article-title":"Molecular classification of breast cancer","volume":"27","author":"Tsang","year":"2020","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib260","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2164-10-135","article-title":"Comparative expression pathway analysis of human and canine mammary tumors","volume":"10","author":"Uva","year":"2009","journal-title":"BMC Genom."},{"key":"10.1016\/j.critrevonc.2026.105184_bib261","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.623800","article-title":"From conventional to precision therapy in canine mammary cancer: a comprehensive review","volume":"8","author":"Valdivia","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib262","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2019.11052","article-title":"Prognostic phenotypic classification for canine mammary tumors","author":"Varallo","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105184_bib263","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/1947-2714.157476","article-title":"Tumor-suppressor genes, cell cycle regulatory checkpoints, and the skin","volume":"7","author":"Velez","year":"2015","journal-title":"North Am. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib264","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105184_bib265","doi-asserted-by":"crossref","first-page":"e703","DOI":"10.1093\/oncolo\/oyad060","article-title":"Characterization of gut microbiome composition in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy","volume":"28","author":"Vernaci","year":"2023","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2026.105184_bib266","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ebiom.2017.03.027","article-title":"Telomeres and Cell Senescence - Size Matters Not","volume":"21","author":"Victorelli","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2026.105184_bib267","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.983110","article-title":"COX-2 expression in mammary invasive micropapillary carcinoma is associated with prognostic factors and acts as a potential therapeutic target in comparative oncology","volume":"9","author":"Vieira","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib268","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3727\/096504009X12596189659042","article-title":"Evaluation of molecular markers in canine mammary tumors: correlation with histological grading","volume":"18","author":"Vinothini","year":"2009","journal-title":"Oncol. Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib269","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/cells11121966","article-title":"The senescence markers p16INK4A, p14ARF\/p19ARF, and p21 in organ development and homeostasis","volume":"11","author":"Wagner","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105184_bib270","first-page":"611","article-title":"Prognostic status of p53 gene mutation in canine mammary carcinoma","volume":"21","author":"Wakui","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib271","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2023.151321","article-title":"Understanding cancer stem cells and plasticity: towards better therapeutics","volume":"102","author":"Warrier","year":"2023","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib272","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/or.2016.5236","article-title":"Non-coding RNAs as regulators in epigenetics","volume":"37","author":"Wei","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib273","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trecan.2020.01.004","article-title":"The cancer microbiome: distinguishing direct and indirect effects requires a systemic view","volume":"6","author":"Xavier","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.critrevonc.2026.105184_bib274","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2021.654694","article-title":"LncRNA-42060 regulates tamoxifen sensitivity and tumor development via regulating the miR-204-5p\/SOX4 axis in canine mammary gland tumor cells","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib275","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00432-013-1376-6","article-title":"Vimentin as a poor prognostic factor for triple-negative breast cancer","volume":"139","author":"Yamashita","year":"2013","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib276","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190288","article-title":"Risk factors for distant metastasis of patients with primary triple-negative breast cancer","volume":"39","author":"Yao","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib277","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2460\/ajvr.2001.62.1539","article-title":"Telomere length and telomerase activity in canine mammary gland tumors","volume":"62","author":"Yazawa","year":"2001","journal-title":"ajvr"},{"key":"10.1016\/j.critrevonc.2026.105184_bib278","doi-asserted-by":"crossref","DOI":"10.9775\/kvfd.2013.10450","article-title":"K\u00f6pek Meme T\u00fcm\u00f6rlerinde Bcl-2, Bcl-XL ve Bax Sunulumu \u0130le Apoptotik \u0130ndeksin De\u011ferlendirilmesi","author":"Yildirim","year":"2014","journal-title":"Kafkas Univ. Vet. Fak. Derg."},{"key":"10.1016\/j.critrevonc.2026.105184_bib279","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib280","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib281","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1292\/jvms.14-0104","article-title":"The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors","volume":"76","author":"Yoshida","year":"2014","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105184_bib282","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12917-015-0483-9","article-title":"Reduced canine BRCA2 expression levels in mammary gland tumors","volume":"11","author":"Yoshikawa","year":"2015","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib283","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.3390\/ani12213050","article-title":"The analysis of E-Cadherin, N-Cadherin, Vimentin, HER-2, CEA, CA15-3 and SF expression in the diagnosis of canine mammary tumors","volume":"12","author":"Yu","year":"2022","journal-title":"Animals"},{"key":"10.1016\/j.critrevonc.2026.105184_bib284","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/2159-8290.CD-19-0015","article-title":"Cellular plasticity in cancer","volume":"9","author":"Yuan","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.critrevonc.2026.105184_bib285","first-page":"319","article-title":"Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy?","volume":"29","author":"Zavlaris","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2026.105184_bib286","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tice.2018.07.003","article-title":"Establishment and characterization of a new triple-negative canine mammary cancer cell line","volume":"54","author":"Zhang","year":"2018","journal-title":"Tissue Cell"},{"key":"10.1016\/j.critrevonc.2026.105184_bib287","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20203121","article-title":"The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis","volume":"41","author":"Zhang","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105184_bib288","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.3390\/ijms231810928","article-title":"The relationship of tumor microbiome and oral bacteria and intestinal dysbiosis in canine mammary tumor","volume":"23","author":"Zheng","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.critrevonc.2026.105184_bib289","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.humpath.2013.03.021","article-title":"Novel prognostic markers for patients with triple-negative breast cancer","volume":"44","author":"Zhou","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105184_bib290","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41598-019-57094-3","article-title":"The prognostic and predictive potential of Ki-67 in triple-negative breast cancer","volume":"10","author":"Zhu","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:38:27Z","timestamp":1778794707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":290,"alternative-id":["S1040842826000715"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105184","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hallmarks of cancer in canine mammary tumors: Insights into a potential model for human triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105184"}}